Xeris Biopharma Holdings Inc (XERS)
$10.71 -0.37% Close Oct 30, 2026 Live
Xeris Biopharma stock today
Xeris Biopharma closed at $10.71 on October 30, 2026, down 0.37% on the day. Over the past year it returned +10.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.85 billion.
$6.00$8.00$10.00
NovJan 2026MarMayJulSep
| Period | XERS | S&P 500 (SPY) |
|---|---|---|
| 1 month | +12.0% | -0.9% |
| 3 months | +27.2% | +2.1% |
| Year to date | +36.4% | +11.7% |
| 1 year | +10.3% | +12.4% |
| 3 years | +541.3% | +88.5% |
| 5 years | +475.8% | +76.0% |
Key statistics
- Market value
- $1.85B
- Forward P/E
- 202.3
- Price / sales
- 5.5
- 52-week range
- $5.29 to $11.13
- Next report
- Nov 5, 2026
About Xeris Biopharma
Develops and commercializes pharmaceutical products treating acute and chronic conditions.
Sector: Health Care
More on Xeris Biopharma
- Financials: revenue, earnings and segmentsRevenue +44% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $5,758 today
No forecast, no recommendation. This page describes Xeris Biopharma Holdings Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.